SeaCrest Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $794K | Sell |
6,283
-163
| -3% | -$21.5K | 0.09% | 197 |
|
|
2026
Q1 | $898K | Buy |
6,446
+66
| +1% | +$9.24K | 0.1% | 210 |
|
|
2025
Q4 | $793K | Sell |
6,380
-6
| -0.1% | -$729 | 0.08% | 230 |
|
|
2025
Q3 | $755K | Sell |
6,386
-141
| -2% | -$16K | 0.08% | 229 |
|
|
2025
Q2 | $724K | Sell |
6,527
-54
| -0.8% | -$5.75K | 0.08% | 233 |
|
|
2025
Q1 | $737K | Sell |
6,581
-311
| -5% | -$32.1K | 0.08% | 240 |
|
|
2024
Q4 | $637K | Sell |
6,892
-60
| -0.9% | -$5.4K | 0.07% | 278 |
|
|
2024
Q3 | $583K | Sell |
6,952
-750
| -10% | -$57.2K | 0.06% | 307 |
|
|
2024
Q2 | $528K | Sell |
7,702
-1,748
| -18% | -$117K | 0.06% | 302 |
|
|
2024
Q1 | $692K | Sell |
9,450
-682
| -7% | -$52.4K | 0.08% | 247 |
|
|
2023
Q4 | $844K | Sell |
10,132
-283
| -3% | -$22K | 0.1% | 203 |
|
|
2023
Q3 | $780K | Sell |
10,415
-80
| -0.8% | -$6.15K | 0.1% | 216 |
|
|
2023
Q2 | $809K | Sell |
10,495
-3,994
| -28% | -$319K | 0.1% | 213 |
|
|
2023
Q1 | $1.2M | Sell |
14,489
-2,336
| -14% | -$193K | 0.16% | 134 |
|
|
2022
Q4 | $1.44M | Sell |
16,825
-6,013
| -26% | -$476K | 0.21% | 101 |
|
|
2022
Q3 | $1.41M | Buy |
22,838
+5,024
| +28% | +$317K | 0.21% | 96 |
|
|
2022
Q2 | $1.1M | Sell |
17,814
-1,246
| -7% | -$77.1K | 0.14% | 153 |
|
|
2022
Q1 | $1.13M | Buy |
19,060
+9,396
| +97% | +$601K | 0.13% | 169 |
|
|
2021
Q4 | $702K | Sell |
9,664
-998
| -9% | -$68.7K | 0.08% | 258 |
|
|
2021
Q3 | $745K | Sell |
10,662
-501
| -4% | -$35.2K | 0.09% | 235 |
|
|
2021
Q2 | $769K | Buy |
11,163
+433
| +4% | +$28.9K | 0.09% | 235 |
|
|
2021
Q1 | $693K | Buy |
10,730
+1,384
| +15% | +$89.2K | 0.09% | 238 |
|
|
2020
Q4 | $545K | Sell |
9,346
-5,101
| -35% | -$308K | 0.08% | 270 |
|
|
2020
Q3 | $913K | Sell |
14,447
-836
| -5% | -$58K | 0.15% | 154 |
|
|
2020
Q2 | $1.18M | Sell |
15,283
-4,118
| -21% | -$316K | 0.2% | 106 |
|
|
2020
Q1 | $1.45M | Buy |
19,401
+14,318
| +282% | +$989K | 0.31% | 73 |
|
|
2019
Q4 | $330K | Sell |
5,083
-1,116
| -18% | -$72.7K | 0.06% | 378 |
|
|
2019
Q3 | $393K | Buy |
6,199
+94
| +2% | +$6.14K | 0.07% | 322 |
|
|
2019
Q2 | $412K | Buy |
6,105
+257
| +4% | +$16.9K | 0.08% | 288 |
|
|
2019
Q1 | $380K | Sell |
5,848
-455
| -7% | -$30.2K | 0.07% | 296 |
|
|
2018
Q4 | $394K | Sell |
6,303
-1,478
| -19% | -$103K | 0.08% | 256 |
|
|
2018
Q3 | $601K | Buy |
7,781
+2,852
| +58% | +$215K | 0.1% | 216 |
|
|
2018
Q2 | $349K | Sell |
4,929
-283
| -5% | -$20K | 0.06% | 341 |
|
|
2018
Q1 | $393K | Buy |
5,212
+362
| +7% | +$28.8K | 0.07% | 298 |
|
|
2017
Q4 | $347K | Buy |
+4,850
| New | +$368K | 0.06% | 333 |
|
Other funds holding GILD
SeaCrest Wealth Management's GILD Position: Q2 2026 in Review
SeaCrest Wealth Management reduced its Gilead Sciences (GILD) stake by 2.5% in Q2 2026, selling an estimated $21.5K and leaving 6,283 shares worth $794K. The position accounts for 0.09% of the portfolio, ranked #197.
SeaCrest Wealth Management first reported a position in GILD in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.45M in Q1 2020. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- SeaCrest Wealth Management held 6,283 shares of Gilead Sciences worth $794K as of Q2 2026.
- SeaCrest Wealth Management sold 163 Gilead Sciences shares in Q2 2026, an estimated $21.5K.
- Gilead Sciences made up 0.09% of SeaCrest Wealth Management's portfolio in Q2 2026, its #197 holding.
- SeaCrest Wealth Management first reported a position in Gilead Sciences in Q4 2017 and has held it in 35 quarters since.
- SeaCrest Wealth Management's Gilead Sciences position peaked at $1.45M in Q1 2020.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.